查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
癌症生物製品市场，按类型、按应用、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1397151

癌症生物製品市场，按类型、按应用、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Cancer Biologics Market, By Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年癌症生物製品市场规模为 1,135.004 亿美元，2023 年至 2030 年复合CAGR为 8.1%。

癌症生物製品市场-市场动态

癌症盛行率的上升和癌症生物技术的进步预计将推动癌症生物製品市场的成长

随着癌症病例数量的持续增加，对更有效、更有针对性的癌症治疗的需求也不断增加。癌症生物製剂可以专门针对癌细胞或通路，为改善治疗结果提供了一条有希望的途径。根据国际癌症研究机构 GLOBOCAN 2020 估计，2020 年全球约有 1,930 万新发癌症病例（不包括非黑色素瘤皮肤癌），近 1,000 万人因癌症死亡（不包括非黑色素瘤皮肤癌）。仅各州， 2020 年就报告了1,603,844 例新癌症病例和602,347 例癌症相关死亡，每10 万人报告了403 例新癌症病例和144 例癌症相关死亡。生物技术的进步促进了更精确和个人化治疗方法的发展。生物技术的进步为更精确和个人化的治疗方法铺平了道路。此外，研发投资的增加推动了癌症生物製剂市场的成长机会。然而，生物製品的研究、开发和生产相关的高成本对市场成长构成了挑战。

癌症生物製品市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球癌症生物製品市场在预测期内（2023-2030 年）每年将以 8.1% 左右的CAGR成长

根据类型细分，预计单株抗体将在 2022 年显示最大的市场份额

根据应用细分，乳癌是 2022 年的主导类型

根据最终用户细分，医院是 2022 年的领先类型

按地区划分，北美是 2022 年的主要收入来源

癌症生物製品市场-細項分析：

全球癌症生物製品市场根据类型、应用、最终用户和地区进行细分。

市场依类型分为三类：单株抗体、疫苗、细胞和基因治疗等。单株抗体是市场的主导力量，在各个领域发挥影响力。它们的应用范围广泛，包括癌症治疗、自体免疫疾病的管理和传染病的治疗。当谈到癌症时，单株抗体具有特异性靶向癌细胞中发现的蛋白质的能力。另一方面，在自体免疫疾病领域，它们可以有效调节免疫反应。

根据应用，市场分为两类：非小细胞肺癌、摄护腺癌、乳癌、急性骨髓性白血病、淋巴瘤、多发性骨髓瘤、卵巢癌、大肠直肠癌、胃癌等。乳癌在市场上占有重要份额。它属于肿瘤学或癌症护理领域，而呼吸健康和诊断则包括肺部评估设备。

根据最终用户，市场分为两类：医院、诊所和其他。医院产业在市场上占有重要地位，其中肺部评估设备市场是重要组成部分。医院是使用各种诊断和监测设备（包括肺部评估设备）的主要医疗保健提供者。

癌症生物製品市场 - 地理洞察

癌症生物製品市场涵盖范围广泛，横跨北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些区域根据对市场做出贡献的国家进一步细分。由于其先进的医疗基础设施，北美地区预计将引领市场成长。尤其是美国，人均医疗保健支出和占GDP的比重都很高，明显高于其他高收入国家。然而，美国是唯一没有全民健康覆盖的国家。根据医疗保险和医疗补助服务中心的数据，2021 年，美国的国家医疗保健支出达到 4.3 兆美元，即人均 12,914 美元，预计到 2028 年将达到 6.2 兆美元。与大多数国家相比，美国的医疗保健系统也更加昂贵，2019 年医疗保健支出占 GDP 的近 16.8%。相比之下，德国的支出为 11.7%，瑞士的支出为 11.3%。在标靶治疗的扩展和免疫疗法的进步的推动下，欧洲是第二大癌症生物製品市场。

癌症生物製品市场-竞争格局：

癌症生物製品市场涵盖多种产品，例如单株抗体、重组治疗蛋白、疫苗、血液和血液成分、细胞疗法和基因疗法。由于重组 DNA 技术的进步，生物製剂在製药业中变得非常重要，使得单株抗体和融合蛋白等产品的大规模生产成为可能。此外，分析技术得到了改进，促进了生物製剂的更好表征以及具有复杂结构和治疗功能的新型生物製剂的发现。此外，高技能生物技术专业人员回流中国缩小了跨国公司与本土竞争对手之间的技术差距。公司通常会组成策略联盟，以增强其能力、扩大其产品组合或进入新市场。癌症生物製剂市场的竞争分析涉及评估该领域公司的动态、策略和定位。拥有处于不同发展阶段的强大癌症生物製剂产品线的公司可能在未来的市场占有率方面拥有竞争优势。

最近的发展：

2021 年 7 月 27 日 - 安进 (Amgen) 和 Teneobio 今天宣布，安进 (Amgen) 将收购 Teneobio，这是一家私营临床阶段生物技术公司，研究一类名为人类重链抗体的新型生物製剂。

目录

第 1 章：癌症生物製品市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的癌症生物製品市场片段
    • 癌症生物製品市场片段（按应用）
    • 最终用户的癌症生物製品市场片段
    • 按国家/地区分類的癌症生物製品市场摘要
    • 按地区分類的癌症生物製品市场片段
  • 竞争洞察

第 3 章：癌症生物製品主要市场趋势

  • 癌症生物製品市场驱动因素
    • 市场驱动因素的影响分析
  • 癌症生物製品市场限制
    • 市场限制影响分析
  • 癌症生物製品市场机会
  • 癌症生物製品市场未来趋势

第 4 章：癌症生物製品产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：癌症生物製品市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：癌症生物製品市场格局

  • 2022 年癌症生物製品市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：癌症生物製品市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 单株抗体
    • 疫苗
    • 细胞和基因治疗
    • 其他的

第 8 章：癌症生物製剂市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 非小细胞肺癌
    • 摄护腺癌
    • 乳癌
    • 急性骨髓性白血病
    • 淋巴瘤
    • 多发骨髓瘤
    • 卵巢癌
    • 大肠直肠癌
    • 胃癌
    • 其他的

第 9 章：癌症生物製品市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊所
    • 其他的

第 10 章：癌症生物製品市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美癌症生物製品主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲癌症生物製品主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区癌症生物製剂主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲癌症生物製品主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲癌症生物製品主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 癌症生物製品产业

  • 竞争仪表板
  • 公司简介
    • Merck & Co., Inc.
    • Novartis International AG
    • F. Hoffmann-La Roche AG
    • Eli Lilly and Company
    • Bristol-Myers Squibb Company
    • Amgen Inc.
    • Pfizer Inc.
    • Sanofi SA
    • Bayer AG
    • EnGeneIC Ltd
    • GlaxoSmithKline PLC. XX
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1922

REPORT HIGHLIGHT

Cancer Biologics Market size was valued at USD 113,500.4 Million in 2022, expanding at a CAGR of 8.1% from 2023 to 2030.

Biological therapy, a form of cancer treatment, harnesses the body's immune system to eliminate cancer cells. This approach has the potential to impede or decelerate tumor growth and halt the spread of cancer. In conjunction with surgery, chemotherapy, or radiation therapy, cancer biologics are frequently employed. The utilization and advancement of cancer biologics signify a significant breakthrough in the realm of oncology, offering more precise and less harmful treatment alternatives for certain cancer types. Moreover, through contemporary laboratory techniques, scientists can generate substantial quantities of Biological Response Modifiers (BRMs) for the treatment of cancer and other ailments like rheumatoid arthritis and Crohn's disease. Unlike conventional chemotherapy, which employs chemical compounds to eradicate rapidly dividing cells, cancer biologics aim to disrupt specific pathways or molecules associated with cancer progression.

Cancer Biologics Market- Market Dynamics

Rise in prevalence of cancer and advancements in cancer biotechnology are expected to drive the growth of cancer Biologics Market

The demand for more effective and targeted cancer treatments is increasing as the number of cancer cases continues to rise. Cancer biologics, which can specifically target cancer cells or pathways, offer a promising avenue for improving therapeutic outcomes. According to the International Agency for Research on Cancer's GLOBOCAN 2020 estimates, there were approximately 19.3 million new cancer cases (excluding non-melanoma skin cancer) and nearly 10.0 million cancer deaths (excluding non-melanoma skin cancer) worldwide in 2020. In the United States alone, there were 1,603,844 new cancer cases reported and 602,347 cancer-related deaths in 2020, with a reported rate of 403 new cancer cases and 144 cancer-related deaths per 100,000 people. Advances in biotechnology have led to the development of more precise and personalized treatment approaches. The advancements in biotechnology have paved the way for more precise and personalized treatment approaches. Moreover, the growth opportunity of the cancer biologics market is fueled by increasing investments in research and development. However, the high costs associated with the research, development, and production of biologics pose a challenge to market growth.

Cancer Biologics Market- Key Insights

  • As per the analysis shared by our research analyst, the global Cancer Biologics market is estimated to grow annually at a CAGR of around 8.1% over the forecast period (2023-2030)
  • Based on Type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2022
  • Based on application segmentation, Breast cancer was the leading type in 2022
  • Based on End-User segmentation, hospitals were the leading type in 2022
  • based on region, North America was the leading revenue generator in 2022

Cancer Biologics Market- Segmentation Analysis:

The Global Cancer Biologics Market is segmented based on Type, Application, End-User, and Region.

The market is divided into three categories based on Type: Monoclonal Antibodies, Vaccines, Cell and Gene Therapy, and Others. Monoclonal antibodies are the leading force in the market, exerting their influence across various fields. Their applications span a wide spectrum, encompassing cancer treatment, management of autoimmune diseases, and therapy for infectious diseases. When it comes to cancer, mAbs possess the ability to specifically target proteins found in cancer cells. On the other hand, in the realm of autoimmune diseases, they can effectively regulate the immune response.

The market is divided into two categories based on application: Non-Small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, and Others. Breast cancer holds a significant share in the market. It belongs to the field of oncology or cancer care, whereas respiratory health and diagnostics encompass lung assessment devices.

The market is divided into two categories based on End-User: Hospitals, Clinics, and Others. The hospital industry holds a strong position in the market, with the Lung Assessment Devices market being a crucial component. Hospitals are the primary healthcare providers that use a variety of diagnostic and monitoring devices, including lung assessment devices.

Cancer Biologics Market- Geographical Insights

The Cancer Biologics Market has a wide geographical reach, spanning across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented based on the countries that contribute to the market. The North American region is expected to lead the market growth, owing to its advanced healthcare infrastructure. The United States, in particular, has a high healthcare spending per person and a share of GDP, which is significantly higher than other high-income countries. However, the US is the only country without universal health coverage. In 2021, the national healthcare expenditure in the US reached USD 4.3 trillion, or USD 12,914 per person, and is projected to reach USD 6.2 trillion by 2028, according to the Centers for Medicare and Medicaid Services. The US healthcare system is also more expensive compared to most countries, with nearly 16.8% of GDP spent on healthcare in 2019. In contrast, Germany spent 11.7% and Switzerland spent 11.3%. Europe is the second-largest Cancer Biologics Market, driven by the expansion of targeted therapies and advancements in immunotherapies.

Cancer Biologics Market- Competitive Landscape:

The cancer biologics market encompasses a diverse array of products, such as monoclonal antibodies, recombinant therapeutic proteins, vaccines, blood and blood components, cell therapy, and gene therapy. Biologics have gained significant importance in the pharmaceutical industry due to advancements in recombinant DNA technologies, enabling large-scale production of products like mAbs and fusion proteins. Furthermore, analytical technologies have improved, facilitating better characterization of biologics and the discovery of novel biologics with intricate structures and therapeutic functions. Moreover, the return of highly skilled biotech professionals to China has bridged the technological gap between multinational companies and local competitors. Strategic alliances are often formed by companies to enhance their capabilities, expand their product portfolios, or enter new markets. Competitive analysis of the cancer biologics market involves evaluating the dynamics, strategies, and positioning of companies operating in this sector. Companies with a robust pipeline of cancer biologics at various stages of development may possess a competitive edge in terms of future market presence.

Recent Developments:

July 27, 2021 - Amgen and Teneobio announced today that Amgen would purchase Teneobio, a privately owned clinical-stage biotechnology business researching a novel class of biologics known as Human Heavy-Chain Antibodies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER BIOLOGICS MARKET KEY PLAYERS

  • Merck & Co., Inc.
  • Novartis International AG
  • F. Hoffmann-La Roche AG
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Amgen Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Bayer AG
  • EnGeneIC Ltd
  • GlaxoSmithKline PLC. XX
  • Others

GLOBAL CANCER BIOLOGICS MARKET, BY TYPE

  • Monoclonal Antibodies
  • Vaccines
  • Cell and Gene Therapy
  • Others

GLOBAL CANCER BIOLOGICS MARKET, BY APPLICATION

  • Non-Small Cell Lung Cancer
  • Prostate Cancer
  • Breast Cancer
  • Acute Myeloid Leukemia
  • Lymphoma
  • Multiple Myeloma
  • Ovarian Cancer
  • Colorectal Cancer
  • Gastric Cancers
  • Others

GLOBAL CANCER BIOLOGICS MARKET, BY END-USER

  • Hospitals
  • Clinics
  • Others

GLOBAL CANCER BIOLOGICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Biologics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Biologics Market Snippet by Type
    • 2.1.2. Cancer Biologics Market Snippet by Application
    • 2.1.3. Cancer Biologics Market Snippet by End-User
    • 2.1.4. Cancer Biologics Market Snippet by Country
    • 2.1.5. Cancer Biologics Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Biologics Key Market Trends

  • 3.1. Cancer Biologics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Biologics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Biologics Market Opportunities
  • 3.4. Cancer Biologics Market Future Trends

4. Cancer Biologics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Biologics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cancer Biologics Market Landscape

  • 6.1. Cancer Biologics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Biologics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Monoclonal Antibodies
    • 7.1.3. Vaccines
    • 7.1.4. Cell and Gene Therapy
    • 7.1.5. Others

8. Cancer Biologics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Non-Small Cell Lung Cancer
    • 8.1.3. Prostate Cancer
    • 8.1.4. Breast Cancer
    • 8.1.5. Acute Myeloid Leukemia
    • 8.1.6. Lymphoma
    • 8.1.7. Multiple Myeloma
    • 8.1.8. Ovarian Cancer
    • 8.1.9. Colorectal Cancer
    • 8.1.10. Gastric Cancers
    • 8.1.11. Others

9. Cancer Biologics Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Cancer Biologics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cancer Biologics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cancer Biologics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cancer Biologics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cancer Biologics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cancer Biologics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Cancer Biologics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Merck & Co., Inc.
    • 11.2.2. Novartis International AG
    • 11.2.3. F. Hoffmann-La Roche AG
    • 11.2.4. Eli Lilly and Company
    • 11.2.5. Bristol-Myers Squibb Company
    • 11.2.6. Amgen Inc.
    • 11.2.7. Pfizer Inc.
    • 11.2.8. Sanofi S.A.
    • 11.2.9. Bayer AG
    • 11.2.10. EnGeneIC Ltd
    • 11.2.11. GlaxoSmithKline PLC. XX
    • 11.2.12. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cancer Biologics Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Cancer Biologics Market, by Type 2018-2030 (USD Million)
  • TABLE Cancer Biologics Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cancer Biologics Market, by Application 2018-2030 (USD Million)
  • TABLE Cancer Biologics Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Cancer Biologics Market, by End-User 2018-2030 (USD Million)
  • TABLE Cancer Biologics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cancer Biologics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Cancer Biologics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Cancer Biologics Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Cancer Biologics Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Cancer Biologics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Cancer Biologics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Cancer Biologics Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Cancer Biologics Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Cancer Biologics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Biologics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Biologics Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Biologics Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Biologics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Biologics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Biologics Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Biologics Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Biologics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Biologics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Biologics Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Biologics Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Biologics Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Cancer Biologics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Cancer Biologics Market share and leading players, 2022
  • FIGURE Europe Cancer Biologics Market share and leading players, 2022
  • FIGURE Asia Pacific Cancer Biologics Market share and leading players, 2022
  • FIGURE Latin America Cancer Biologics Market share and leading players, 2022
  • FIGURE Middle East and Africa Cancer Biologics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Cancer Biologics Market share analysis by country, 2022
  • FIGURE Germany Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Cancer Biologics Market share analysis by country, 2022
  • FIGURE India Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Biologics Market share analysis by country, 2022
  • FIGURE Brazil Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Biologics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)